These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7325774)

  • 21. [Results of clinical investigation in patients with multiple sclerosis (author's transl)].
    Ladurner G; Schraml H; Sager WD; Flooh E; Lepuschütz H; Lechner H
    Nervenarzt; 1981 Jun; 52(6):340-3. PubMed ID: 7266697
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of evoked potentials in the diagnosis and follow-up of multiple sclerosis.
    Drislane FW
    Clin Neurosci; 1994; 2(3-4):196-201. PubMed ID: 7749888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The diagnostic value of vestibular evoked myogenic potentials in multiple sclerosis.
    Bandini F; Beronio A; Ghiglione E; Solaro C; Parodi RC; Mazzella L
    J Neurol; 2004 May; 251(5):617-21. PubMed ID: 15164200
    [No Abstract]   [Full Text] [Related]  

  • 24. Correlations of evoked potentials with MR imaging and MR spectroscopy in multiple sclerosis.
    Kraft GH; Richards TL; Heide AC
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):561-7, vi. PubMed ID: 9894109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.
    Fraser C; Klistorner A; Graham S; Garrick R; Billson F; Grigg J
    Arch Neurol; 2006 Jun; 63(6):847-50. PubMed ID: 16769865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple sclerosis and intrathecal IgA synthesis.
    Sena A; Rosado P; Ferret-Sena V; Coimbra J; Schuller E; Sindic CJ
    Acta Neurol Belg; 1997 Mar; 97(1):36-8. PubMed ID: 9107343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caveat regarding immunoglobulin therapy in multiple sclerosis.
    Cross AH; Trotter JL; Hart WM
    Ann Neurol; 1993 Jun; 33(6):660-1. PubMed ID: 8338598
    [No Abstract]   [Full Text] [Related]  

  • 28. [Visual evoked potentials (VEP). Current perspectives].
    Teijeira JM; Montes C; Díaz E; González-Barón S
    Rev Neurol; 1998 Mar; 26(151):451-8. PubMed ID: 9585962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple sclerosis].
    Rumbach L
    Rev Prat; 2005 Jun; 55(11):1249-54. PubMed ID: 16164074
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
    Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
    J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sensitivity of motor evoked potentials in detecting cortico-spinal lesions in patients with multiple sclerosis].
    Gómez-Fernández L; Minou-Báez M; Cabrera-Gómez JA
    Rev Neurol; 1999 Feb 16-28; 28(4):357-60. PubMed ID: 10714312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Visual evoked potentials: a routine test in the diagnosis of multiple sclerosis].
    Franck H; Middleton L
    Bull Soc Ophtalmol Fr; 1981 Oct; 81(10):823-5. PubMed ID: 7332987
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical update on optic neuritis and multiple sclerosis.
    Murphy MA
    Med Health R I; 2008 Feb; 91(2):57-9. PubMed ID: 18372861
    [No Abstract]   [Full Text] [Related]  

  • 34. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
    Alshuaib WB
    Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medullar and supraspinal conduction in multiple sclerosis: localization value (author's transl)].
    Obeso JA; Marti Massó JF; Carrera N
    Med Clin (Barc); 1980 Mar; 74(5):183-7. PubMed ID: 7382611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sympathetic skin response (SSR) is abnormal in multiple sclerosis.
    Elie B; Louboutin JP
    Muscle Nerve; 1995 Feb; 18(2):185-9. PubMed ID: 7823976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of evoked potentials in neurological clinical practice].
    Kundra O
    Ideggyogy Sz; 2005 Nov; 58(11-12):364-79. PubMed ID: 16491562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, magnetic resonance imaging, cerebrospinal fluid and electrophysiological characteristics of the earliest multiple sclerosis.
    Rot U; Ledinek AH; Jazbec SS
    Clin Neurol Neurosurg; 2008 Mar; 110(3):233-8. PubMed ID: 18093725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis.
    Frohman EM; Costello F; Stüve O; Calabresi P; Miller DH; Hickman SJ; Sergott R; Conger A; Salter A; Krumwiede KH; Frohman TC; Balcer L; Zivadinov R
    Arch Neurol; 2008 Jan; 65(1):26-35. PubMed ID: 18195137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can abnormal evoked potentials predict future clinical disability in patients with multiple sclerosis?
    Mastaglia FL
    Nat Clin Pract Neurol; 2006 Jun; 2(6):304-5. PubMed ID: 16932572
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.